BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 15453039)

  • 1. [Fatal miliary tuberculosis following treatment with Infliximab].
    Karoui S; Bouallegue L; Hamzaoui S; Filali A; Boubaker J
    Tunis Med; 2004 Apr; 82(4):393-6. PubMed ID: 15453039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Fatal miliary tuberculosis during treatment with infliximab].
    Vonkeman HE; van der Valk PD; Mulder L; van de Laar MA
    Ned Tijdschr Geneeskd; 2002 Jun; 146(25):1196-9. PubMed ID: 12109312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-TNF treatment and miliary tuberculosis in Crohn's disease.
    Milenković B; Dudvarski-Ilić A; Janković G; Martinović L; Mijac D
    Srp Arh Celok Lek; 2011; 139(7-8):514-7. PubMed ID: 21980664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Miliary tuberculosis following infliximab therapy for Crohn disease: A case report and review of the literature.
    Stas P; D'Hoore A; Van Assche G; Geboes K; Steenkiste E; Penninckx F; Rutgeerts P; Vermeire S
    Acta Gastroenterol Belg; 2006; 69(2):217-20. PubMed ID: 16929619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of fatal tuberculosis in a patient with rheumatoid arthritis after three years of treatment with infliximab: comment on the article by Wolfe et al.
    Molenaar ET; Bultink IE; Dijkmans BA; Lems WF
    Arthritis Rheum; 2005 Apr; 52(4):1334-6. PubMed ID: 15818690
    [No Abstract]   [Full Text] [Related]  

  • 6. [Disseminated tuberculosis following infliximab therapy for Crohn disease: a case report].
    Bouchentouf R; Yasser Z; Aitbenasser MA
    Rev Pneumol Clin; 2014 Dec; 70(6):366-9. PubMed ID: 25131370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Indications and results of infliximab in Crohn's disease].
    Karoui S; Boubaker J; Filali A
    Tunis Med; 2004 Dec; 82(12):1057-63. PubMed ID: 15822505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Case of miliary tuberculosis during treatment with infliximab for rheumatoid arthritis].
    Taniguchi H; Izumi S
    Kekkaku; 2008 May; 83(5):431-4. PubMed ID: 18536334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pneumocystis pneumonia during infliximab treatment for active Crohn's colitis].
    Minnee RC; Stokkers P; Riemens SC; Hommes DW
    Ned Tijdschr Geneeskd; 2005 Oct; 149(41):2290-5. PubMed ID: 16240855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of miliary tuberculosis under infliximab in a patient with spondyloarthritis and suspected Crohn's disease.
    Koschny R; Junghanss T; Mischnik A; Karner M; Kreuter M; Roth W; Stremmel W; Merle U
    Z Gastroenterol; 2013 Oct; 51(10):1177-83. PubMed ID: 24122379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disseminated primary varicella after initiation of infliximab for Crohn's disease.
    Leung VS; Nguyen MT; Bush TM
    Am J Gastroenterol; 2004 Dec; 99(12):2503-4. PubMed ID: 15571606
    [No Abstract]   [Full Text] [Related]  

  • 12. Autoantibody profile during short-term infliximab treatment for Crohn's disease: a prospective cohort study.
    Atzeni F; Ardizzone S; Sarzi-Puttini P; Colombo E; Maconi G; De Portu S; Carrabba M; Bianchi Porro G
    Aliment Pharmacol Ther; 2005 Sep; 22(5):453-61. PubMed ID: 16128684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maintenance infliximab does not result in increased abscess development in fistulizing Crohn's disease: results from the ACCENT II study.
    Sands BE; Blank MA; Diamond RH; Barrett JP; Van Deventer SJ
    Aliment Pharmacol Ther; 2006 Apr; 23(8):1127-36. PubMed ID: 16611273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guidelines for treatment with infliximab for Crohn's disease.
    Hommes DW; Oldenburg B; van Bodegraven AA; van Hogezand RA; de Jong DJ; Romberg-Camps MJ; van der Woude J; Dijkstra G;
    Neth J Med; 2006; 64(7):219-29. PubMed ID: 16929083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infliximab in the surgical management of complex fistulating anal Crohn's disease.
    Talbot C; Sagar PM; Johnston MJ; Finan PJ; Burke D
    Colorectal Dis; 2005 Mar; 7(2):164-8. PubMed ID: 15720356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multidrug resistant miliary tuberculosis during infliximab therapy despite tuberculosis screening.
    Gin A; Dolianitis C
    Australas J Dermatol; 2014 May; 55(2):140-1. PubMed ID: 23713793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fistulating anal Crohn's disease: results of combined surgical and infliximab treatment.
    Hyder SA; Travis SP; Jewell DP; McC Mortensen NJ; George BD
    Dis Colon Rectum; 2006 Dec; 49(12):1837-41. PubMed ID: 17041753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Life-threatening disseminated tuberculosis as a complication of treatment by infliximab for Crohn's disease: report of two cases, including cerebral tuberculomas and miliary tuberculosis.
    Tissot C; Couraud S; Meng L; Girard P; Avrillon V; Gérinière L; Perrot E; Souquet PJ
    J Crohns Colitis; 2012 Oct; 6(9):946-9. PubMed ID: 22749231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Tuberculosis associated with hemophagocytic syndrome complicated by treatment with infliximab].
    Numakura T; Matsuura Y; Takiguchi H; Hara Y; Ameku K; Takashi H
    Nihon Kokyuki Gakkai Zasshi; 2010 Jun; 48(6):449-53. PubMed ID: 20608090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Anti-TNF (infliximab) treatment in Crohn disease: safety profile].
    Carroccio A; Di Prima L; Pirrone G; Ambrosiano G; Noto D; Cefalù AB
    Recenti Prog Med; 2006 Feb; 97(2):108-12; quiz 122. PubMed ID: 16671277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.